Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Eagle Bancorp Inc (EGBN)
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
$33.61-2.30%
Close 2026-11-05 · 1-day change
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
2.32 → 2.45 EPS · FY ending Dec 31, 2027 · 5 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 5; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for EGBN yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Manage noninterest expenses to improve cost efficiency | Costs are falling, with noninterest expenses down $21.1M. | Under Pressure | noninterest expense rises above $48.7M over next 4 quarters | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a regional bank recovery thesis, not a proven durable growth story. The thesis is in a watch state: momentum improved and the latest earnings report was positive, but recent financial performance remains weak relative to its industry cohort.
The valuation signal is mixed: EGBN is described as cheap versus peers, while the model also indicates a 73% premium versus peers and labels expectations stretched. The expectations gap is 0.24, but the evidence does not explain what specific results the market assumes.
Near term, earnings may remain uneven: third-quarter net income rose from the prior quarter, mainly because provision expense was lower, while revenue had declined from the first to second quarter. Asset quality remains a key concern, as nonperforming assets rose in the latest quarter even as criticized loan balances fell; deposits also declined, despite growth in commercial deposits.
The multi-year thesis hinges on resolving problem assets, stabilizing deposits, and showing consistent profitable growth. Near term, a guidance cut or falling rates could weigh on the business, while continued earnings strength and higher guidance from sector bellwethers could support sector momentum.
Over the next 1 to 3 years, EGBN’s long-term thesis remains uncertain: recent momentum and the latest earnings report are constructive, but asset quality, growth consistency, and funding trends need clearer improvement. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Credit risk is being managed with CRE concentration down from 336.6% to 295.1%. |
| Intact |
| CRE concentration ratio rises above 295.1% over next 4 quarters |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Return to sustained profitability with net income growth | A primary condition in Eagle Bancorp Inc's published investment case. The stated target is net income > $14.7M. | Intact | net income falls below $14.7M over next 4 quarters | Net income: $24.246M FY2026-Q3; GAAP. Published target: net income > $14.7M. Reported actuals cannot certify a consensus target without an explicit period and accounting-basis binding. Oct 21, 202624,246,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Successful CEO transition to Stephen R. Curley | A supporting condition in Eagle Bancorp Inc's published investment case. The stated target is stable leadership and execution progress. | Intact | leadership instability or strategic setbacks reported | Leadership stable; 2027 NIM guide 2.77%-3.05% vs qualitative target Stephen Curley appointed CEO; recent earnings beat; 2027 NIM guidance provided; no leadership instability reported. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$2.61 → $2.45 · observed estimates
$0.32B → $0.30B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $2.61 | $316,990,475 | 4 / 4 |
| 2026-07-25 | $2.61 | $279,451,000 | 5 / 5 |
| 2026-07-26 | $2.61 | $316,990,475 | 4 / 4 |
| 2026-07-27 | $2.61 | $279,451,000 | 5 / 5 |
| 2026-07-28 | $2.61 | $316,990,475 | 4 / 4 |
| 2026-07-29 | $2.59 | $269,874,800 | 4 / 5 |
| 2026-07-30 | $2.59 | $269,874,800 | 4 / 5 |
| 2026-07-31 | $2.59 | $269,874,800 | 4 / 5 |
| 2026-08-01 | $2.43 | $305,020,225 | 3 / 4 |
| 2026-08-02 | $2.52 | $267,734,800 | 4 / 5 |
| 2026-08-03 | $2.43 | $305,020,225 | 3 / 4 |
| 2026-08-04 | $2.43 | $305,020,225 | 3 / 4 |
| 2026-08-05 | $2.43 | $305,020,225 | 3 / 4 |
| 2026-08-06 | $2.44 | $263,095,600 | 4 / 5 |
| 2026-08-07 | $2.32 | $294,985,950 | 3 / 4 |
| 2026-08-08 | $2.45 | $262,695,600 | 4 / 5 |
| 2026-08-09 | $2.45 | $262,695,600 | 4 / 5 |
| 2026-08-10 | $2.32 | $294,985,950 | 3 / 4 |
| 2026-08-11 | $2.32 | $294,985,950 | 3 / 4 |
| 2026-08-12 | $2.51 | $263,195,600 | 4 / 5 |
| 2026-08-13 | $2.51 | $263,195,600 | 4 / 5 |
| 2026-08-14 | $2.32 | $294,985,950 | 3 / 4 |
| 2026-08-15 | $2.32 | $294,985,950 | 3 / 4 |
| 2026-08-16 | $2.32 | $294,985,950 | 3 / 4 |
| 2026-08-17 | $2.32 | $294,985,950 | 3 / 4 |
| 2026-08-18 | $2.32 | $294,985,950 | 3 / 4 |
| 2026-08-19 | $2.32 | $294,985,950 | 3 / 4 |
| 2026-08-20 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-08-21 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-08-22 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-08-23 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-08-24 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-08-25 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-08-26 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-08-27 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-08-28 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-08-29 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-08-30 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-08-31 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-09-01 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-09-02 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-09-03 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-09-04 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-09-05 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-09-06 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-09-07 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-09-08 | $2.37 | $294,985,950 | 3 / 4 |
| 2026-09-09 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-10 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-11 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-12 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-13 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-14 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-15 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-16 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-17 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-18 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-19 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-20 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-21 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-22 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-23 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-24 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-25 | $2.33 | $290,852,000 | 3 / 4 |
| 2026-09-26 | $2.32 | $290,059,750 | 3 / 4 |
| 2026-09-27 | $2.32 | $290,059,750 | 3 / 4 |
| 2026-09-28 | $2.32 | $290,059,750 | 3 / 4 |
| 2026-09-29 | $2.32 | $290,059,750 | 3 / 4 |
| 2026-09-30 | $2.32 | $290,059,750 | 3 / 4 |
| 2026-10-01 | $2.32 | $290,059,750 | 3 / 4 |
| 2026-10-02 | $2.32 | $290,059,750 | 3 / 4 |
| 2026-10-03 | $2.32 | $290,059,750 | 3 / 4 |
| 2026-10-04 | $2.32 | $290,059,750 | 3 / 4 |
| 2026-10-05 | $2.32 | $290,059,750 | 3 / 4 |
| 2026-10-06 | $2.32 | $290,059,750 | 3 / 4 |
| 2026-10-07 | $2.32 | $290,059,750 | 3 / 4 |
| 2026-10-08 | $2.31 | $293,167,800 | 3 / 4 |
| 2026-10-09 | $2.32 | $293,147,800 | 4 / 5 |
| 2026-10-10 | $2.32 | $293,147,800 | 4 / 4 |
| 2026-10-11 | $2.32 | $293,147,800 | 4 / 4 |
| 2026-10-12 | $2.32 | $293,147,800 | 4 / 4 |
| 2026-10-13 | $2.32 | $293,147,800 | 4 / 4 |
| 2026-10-14 | $2.32 | $293,147,800 | 4 / 4 |
| 2026-10-15 | $2.32 | $293,147,800 | 4 / 4 |
| 2026-10-16 | $2.32 | $293,147,800 | 4 / 4 |
| 2026-10-17 | $2.32 | $293,147,800 | 4 / 4 |
| 2026-10-18 | $2.32 | $293,147,800 | 4 / 4 |
| 2026-10-19 | $2.32 | $293,147,800 | 4 / 4 |
| 2026-10-20 | $2.32 | $293,147,800 | 4 / 4 |
| 2026-10-21 | $2.32 | $293,147,800 | 4 / 4 |
| 2026-10-22 | $2.32 | $293,147,800 | 4 / 4 |
| 2026-10-23 | $2.40 | $297,487,800 | 4 / 4 |
| 2026-10-24 | $2.46 | $301,142,800 | 5 / 4 |
| 2026-10-25 | $2.46 | $301,142,800 | 5 / 4 |
| 2026-10-26 | $2.46 | $301,142,800 | 5 / 4 |
| 2026-10-27 | $2.48 | $302,642,800 | 5 / 4 |
| 2026-10-28 | $2.48 | $302,642,800 | 5 / 5 |
| 2026-10-29 | $2.48 | $302,642,800 | 5 / 5 |
| 2026-10-30 | $2.48 | $302,642,800 | 5 / 5 |
| 2026-10-31 | $2.48 | $302,642,800 | 5 / 5 |
| 2026-11-01 | $2.48 | $302,642,800 | 5 / 5 |
| 2026-11-02 | $2.48 | $302,642,800 | 5 / 5 |
| 2026-11-03 | $2.48 | $301,131,740 | 5 / 5 |
| 2026-11-04 | $2.45 | $301,122,800 | 5 / 5 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.